A Blood-Based Multi Marker Assay Supports the Differential Diagnosis of Early-Stage Pancreatic Cancer-Reference-Cited by-同舟云学术

A Blood-Based Multi Marker Assay Supports the Differential Diagnosis of Early-Stage Pancreatic Cancer

Published:2019 Issue:5 Volume:9 Page:1280-1287
ISSN:1838-7640
Container-title:Theranostics
language:en
Short-container-title:Theranostics

Author:

Berger Andreas W.,Schwerdel Daniel,Reinacher-Schick Anke,Uhl Waldemar,Algül Hana,Friess Helmut,Janssen Klaus-Peter,König Alexander,Ghadimi Michael,Gallmeier Eike,Bartsch Detlef K.,Geissler Michael,Staib Ludger,Tannapfel Andrea,Kleger Alexander,Beutel Alica,Schulte Lucas-Alexander,Kornmann Marko,Ettrich Thomas J.,Seufferlein Thomas

Publisher

Ivyspring International Publisher

Subject

Pharmacology, Toxicology and Pharmaceutics (miscellaneous),Medicine (miscellaneous)

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multibiomarker panels in liquid biopsy for early detection of pancreatic cancer – a comprehensive review;Journal of Experimental & Clinical Cancer Research;2024-09-02

2. Molecular pathology and protein markers for pancreatic cancer: relevance in staging, in adjuvant therapy, in determination of minimal residual disease, and follow-up;Hepatobiliary Surgery and Nutrition;2024-02

3. Molecular biomarkers in pancreatic ductal adenocarcinoma;Biomarkers in Cancer Detection and Monitoring of Therapeutics;2024

4. Improving the prognosis of pancreatic cancer: insights from epidemiology, genomic alterations, and therapeutic challenges;Frontiers of Medicine;2023-12-27

5. Coagulation parameters for the differential diagnosis of pancreatic cancer in the early stage: a retrospective study;European Journal of Medical Research;2023-10-17